Rapport Therapeutics soars 23% on release of phase 2 data for seizure asset Rapport Therapeutics soars 23% on release of phase 2 data for seizure asset Post ContentrappRead More You might also be interested in reading How iTrust Finance Scales On-Chain Insurance. September 5, 2025 In Mainstream ← Previous post Next post →